Quest Diagnostics vs West Pharmaceutical Services

Quest Diagnostics (DGX), health care, and West Pharmaceutical Services (WST), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

West Pharmaceutical Services is worth $28.8B on the stock market and Quest Diagnostics $28.2B: West Pharmaceutical Services is valued at 2% more. Quest Diagnostics trades at 25.5 times earnings and West Pharmaceutical Services at 46.5; operating margins in their latest fiscal years were 14.1% and 19.0%. Over the past year Quest Diagnostics's share price has moved +41.5% and West Pharmaceutical Services's +60.6%.

Key facts

Quest Diagnostics market value
$28.2B
West Pharmaceutical Services market value
$28.8B
Quest Diagnostics P/E
25.5
West Pharmaceutical Services P/E
46.5
Quest Diagnostics revenue
$11BFY to 2025-12-31
West Pharmaceutical Services revenue
$3.1BFY to 2025-12-31
Superinvestors holding both
0

Market values as of .

Quest Diagnostics vs West Pharmaceutical Services: every measure side by side
Measure Quest Diagnostics West Pharmaceutical Services
SectorHealth CareHealth Care
Country United States United States
Fiscal year ends2025-12-312025-12-31
Size
Market cap$28.2Blower$28.8Bhigher
Revenue$11Bhigher$3.1Blower
Earnings$992Mhigher$493.7Mlower
Employees60,000higher10,000lower
Total assets$16.2Bhigher$4.3Blower
Valuation
P/E25.5lower46.5higher
P/S2.6lower9.4higher
P/B3.7lower9.7higher
Dividend yield1.29%higher0.21%lower
Profitability
Operating margin14.1%lower19.0%higher
Balance sheet
Net assets$7.2Bhigher$3.2Blower
Total liabilities$8.9Bhigher$1.1Blower
Total debt$5.7Bhigher$202.8Mlower
Cash on hand$420Mlower$791.3Mhigher
Price change
Today-2.23%lower-0.88%higher
1 year+41.5%lower+60.6%higher

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

Loading the one-year price chart…

Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

Both (0)

None of the tracked investors.

Quest Diagnostics only (3)

West Pharmaceutical Services only (3)

Percentages are each holding's share of that investor's reported portfolio. Who owns DGX · Who owns WST

Further comparisons

Learn

Questions and answers

Which is bigger, Quest Diagnostics or West Pharmaceutical Services?

By market value, West Pharmaceutical Services is the larger: $28.8B against $28.2B for Quest Diagnostics. By revenue in its latest fiscal year, Quest Diagnostics is the larger: $11B against $3.1B for West Pharmaceutical Services.

Which has the higher P/E ratio?

West Pharmaceutical Services: 46.5, against 25.5 for Quest Diagnostics. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.

Which has the higher operating margin?

West Pharmaceutical Services: 19.0%, against 14.1% for Quest Diagnostics. Operating margin is operating income as a share of revenue in the latest fiscal year.

Which has the higher dividend yield?

Quest Diagnostics: 1.29%, against 0.21% for West Pharmaceutical Services. Dividend yield is the last twelve months' dividends as a share of today's share price.

Which has more debt?

Quest Diagnostics: $5.7B, against $202.8M for West Pharmaceutical Services. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.

Which superinvestors own both Quest Diagnostics and West Pharmaceutical Services?

None of the tracked superinvestors holds both in their latest 13F filing. 3 hold Quest Diagnostics and 3 hold West Pharmaceutical Services.

Cite this page

Funkfolio, “Quest Diagnostics vs West Pharmaceutical Services”, data as of 18 November 2026. https://funkfolio.com/compare/dgx-vs-wst

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.